DANA WADE: Open Payments
NPI 1659783330 · KINSTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,180 in 72 payments from 14 companies in 2025. Trend: 2023 $1,979 · 2024 $1,368 · 2025 $1,180
Food & beverage: $1,180
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 16 | $206 |
| Novo Nordisk Inc | 13 | $184 |
| GlaxoSmithKline, LLC. | 10 | $182 |
| Novartis Pharmaceuticals Corporation | 9 | $163 |
| Lilly USA, LLC | 4 | $77 |
| ABBVIE INC. | 4 | $76 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| PFIZER INC. | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $40 |
Products named: TRELEGY ELLIPTA, LEQVIO, OTEZLA, Wegovy, UBRELVY, MOUNJARO, EVENITY, REXULTI.
Industry payments across NC — which companies pay providers there.
